ation_NN and_CC the_DT data_NNS ._.
4.1_CD Data_NN Sources_NNS and_CC Domain_NN Knowledge_NN 4.1.1_CD Background_NN :_: Colon_NN Cancer_NN Colon_NN cancer_NN patients_NNS are_VBP grouped_VBN into_IN 4_CD stages_NNS ,_, such_JJ that_IN each_DT group_NN is_VBZ homogeneous_JJ in_IN respect_NN of_IN survival_NN -LRB-_-LRB- 1_CD -RRB-_-RRB- =_SYM -_: =[_NN 27_CD -RRB-_-RRB- -_: =_SYM -_: ._.
Our_PRP$ study_NN focuses_VBZ on_IN Stage_NNP III_NNP cancer_NN patients_NNS :_: roughly_RB 50_CD %_NN of_IN Stage_NNP III_NNP patients_NNS survive_VBP ._.
-LRB-_-LRB- Most_JJS Stage_NN I_CD and_CC II_CD patients_NNS survive_VBP ,_, and_CC virtually_RB all_DT Stage_NNP IV_NNP patients_NNS do_VBP not_RB ._. -RRB-_-RRB-
The_DT key_JJ outcomes_NNS variab_VBP
